Beth Levy, M.D.


Adjunct Professor

University of Missouri- Kansas City MD 1982

Office: University Hospital

Email Address:

CV: Beth Levy, M.D.

Beth Levy, M.D.
Beth Levy, M.D.
Clinical/Research Interests:


Anatomic Pathology


Anatomic Pathology
Clinical Pathology


American Society of Clinical Pathologists
College of American Pathologists
St. Louis Metropolitan Medical Society
Wagih Bari Society of St. Louis Pathologists

Departmental Affiliations

Department of Pathology, Saint Louis University Hospital


1. Galvin, N., Vogler, C., Levy, B., Kovacs, A., Griffey, M., Sands, M.S. A murine model of infantile neuronal ceroid lipofuscinosis - Ultrastructural evaluation of storage in the central nervous system and viscera. Pediatric and Developmental Pathology 11(3):185-192, 2008.

2. Beaty, A.D., Weller, C., Levy, B., Vogler, C., Ferguson, W.S., Bicknese, A., Knutsen, A.P. A teenage boy with late onset hemophagocytic lymphohistiocytosis with predominant neurologic disease and perforin deficiency. Pediatric Blood and Cancer 50(5):1070-1072, 2008.

3. Dickson, P., McEntee, M., Vogler, C., Le, S., Levy, B., Peinovich, M., Hanson, S., Passage, M., Kakkis, E. Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluid. Molecular Genetics and Metabolism 91(1):61-68, 2007.

4. Lin, D., Donsante, A., Macauley, S., Levy, B., Vogler, C., Sands, M.S. Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy. Molecular Therapy 15(1):44-52, 2007.

5. Lessard, M.D., Alley, T.L., Proctor, J.L., Levy, B., Galvin, N., Vogler, C.A., Soper, B.W. Attenuation of murine lysosomal storage disease by allogeneic neonatal bone marrow transplantation using costimulatory blockade and donor lymphocyte infusion without myeloablation. Clinical Immunology 119(2):166-179, 2006.

6. Vogler, C., Levy, B., Grubb, J.H., Galvin, N., Tan, Y., Kakkis, E., Pavloff, N., Sly, W.S. Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. Proceedings of the National Academy of Sciences USA 102(41):14777-14782, 2005.

7. Lin, D., Fantz, C.R., Levy, B., Rafi, M.A., Vogler, C., Wenger, D.A., Sands, M.S. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2. Molecular Therapy 12(3):422-430, 2005.

8. Vogler, C., Levy, B., Galvin, N., Lessard, M., Soper, B., Barker, J. Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: Undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse. Pediatric and Developmental Pathology 8(4):453-462, 2005.

9. Orii, K.O., Grubb, J.H., Vogler, C., Levy, B., Tan, Y., Markova, K., Davidson, B.L., Mao, Q., Orii, T., Kondo, N., Sly, W.S. Defining the pathway for Tat-mediated delivery of β-glucuronidase in cultured cells and MPS VII mice. Molecular Therapy 12(2):345-352, 2005.

10. Kolli, S., Ziaee, A., Lee, R., Lim, M.J., Levy, B., Labovitz, A.J. Myofibroblastic sarcoma of mitral valve: A case report. Journal of the American Society of Echocardiography 18(3):285-286, 2005.

Click here for listings on PubMed

Modified Date:Monday 23-Jul-12 16:43:49 CDT

Next page: Jane McHowat, Ph.D.